Study: Tarceva boosts lung-cancer survival

Roche announced that advanced lung cancer patients lived longer when given Tarceva right after initial chemotherapy, according to new SATURN data. Roche release | Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.